Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Drugs

Drugs

                        


                        Regulatory Science Research and Education
          Development & Approval Process | Drugs
          Drug Safety and Availability
          Emergency Preparedness | Drugs
          Guidance, Compliance, & Regulatory Information
          News & Events for Human Drugs
          Resources | Drugs
          Science and Research | Drugs Home
          Drugs
          CDER WebinarsDrugs CDER Webinars
  
  	
    Share
    Post
    Linkedin

    Email
    PrintUpcoming Webinars

FDA Drug Topics: Tips to Navigating Drug Interaction Information in the US Prescribing Information - February 27, 2024Past 2023 Webinars

FDA Drug Topics: An Overview of Color Additives in Drug Products - Regulation and Enforcement - February 28, 2023
	Cannabis and Cannabis-Derived Products – For Healthcare Practitioners
	Rare Diseases - Challenges and Progress in Drug Development
	How to Avoid Medication Errors with Pen Injectors
	Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers
	Regulatory Framework for Human Drug Compounding
	Naltrexone Injection for Opioid Use Disorder - FDA’s Efforts to Reduce Medication Errors
	FDA Drug Topics: Advancing Transparency and Regulatory Science Activities on the Risk Evaluation and Mitigation Strategy (REMS) - November 28, 2023
	FDA Drug Topics: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program - December 12, 2023Past 2022 Webinars

Frequently Asked Questions about Labeling for Prescription Medicines
	The Safety Evaluation and Surveillance of Generic Drugs
	Understanding Generic Narrow Therapeutic Index Drugs
	Development and U.S. Regulation of Preventative Vaccines
	Drug Shortages: Root Causes and Potential Solutions
	Reporting and Public Viewing of Individual Case Safety Reports (ICSRs)
	FDA Drug Information Resources and Applicability to Health Care Professionals
	Counseling Patients on Generic Drugs
	Biosimilar and Interchangeable Biosimilars: Review of Scientific Concepts, Case Studies, and ResourcesPast 2021 Webinars

Overview of Expanded Access (EA) Program and EA eRequest Site
	Clinical Investigator Training Course (CITC) Update - December 7-8, 2021
	Fraudulent Products – Hidden Ingredients and Unproven Claims in Products Marketed as Dietary Supplements
	How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety
	Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 10/13/2021 - 10/13/2021
	Enhanced Drug Distribution Security in 2023 Under the DSCSA - October 5, 2021
	Investigator Responsibilities — Safety Reporting for Investigational Drugs and Device
	FDA’s Role in Postmarketing Drug Safety Surveillance
	OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees Webinar - 06/03/2021 - 06/03/2021
	Enhanced Drug Distribution Security: 2023 and Beyond
	Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning
	FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update
	The Ins and Outs of Prescription Drug Labeling
	Biosimilar and Interchangeable Biological Products: An Updated Review of Scientific Concepts and Practical ResourcesPast 2020 Webinars

FDA Drug Topics: Role of FDA and ISMP in Preventing Medication Errors – June 30, 2020 (Postponed from March 17, 2020)
	Webinar: CDER SEND Common Issues and Policy Update - June 15, 2020
	Postmarketing Drug Safety Compliance: 2019 Inspection Findings – Apr. 29, 2020
	CDER SEND Common Issues and Policy Update - March 20, 2020
	Learn About ClinicalTrials.gov Modernization and How to Provide Input - March 2, 2020
	FDA Drug Information Resources and Applicability to Health Care Professionals
	On Demand Webinar: Recent Revisions to the ANDA Prioritization MAPP – Jan. 2020Past 2019 Webinars

Webinar: Submitting IND Safety Reports to FDA Adverse Event Reporting System (FAERS) - Nov. 1, 2019
	Webinar: Electronic Submission of Adverse Event Reports to FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) Standards - Oct. 11, 2019
	Most Common Issues with CDISC-SEND Data in FDA Toxicology Review – Sep. 12, 2019
	On-demand Webinar: eCTD Submissions of Promotional Labeling and Advertising Materials – Aug. 12, 2019
	FDA Drug Topics: 3D Printing in Drug Development and Emerging Health Care – May 21, 2019
	An Introduction to FDA MyStudies: An Open-Source, Digital Platform to Gather Real World Data for Clinical Trials and Research Studies – May 9, 2019
	Webinar: Risk-Based Approach to Monitoring Clinical Investigations: Overview of FDA Draft Guidance Issued for Comment
	FDA Drug Topics: An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (CDER) – March 26, 2019
	Webinar: Framework for FDA’s Real-World Evidence Program – Mar 15, 2019Past 2018 Webinars

FDA Drug Topics: Biosimilar and Interchangeable Products in the U.S.: Scientific Concepts, Clinical Use, and Practical Considerations – December 10, 2018
	Final Guidance for Industry: Use of Electronic Health Record Data in Clinical Investigations – December 6, 2018
	FDA Study Data Technical Conformance Guide – November 27, 2018
	FDA Drug Topics: FDA Regulation of Color Additives in Drug Products – November 6, 2018
	An update to the FDA Adverse Event Reporting System (FAERS) Public Dashboard
	Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance
	Building Confidence in Generic Narrow Therapeutic Index (NTI) Drugs
	Deeper Dive Webinar: Postmarketing Drug Safety and Inspection Readiness - June 19, 2018
	Updates to Forms 356h & 1571: Commercial vs. Research, Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT), Combination Products
	Optimizing Your Study Data Submissions to FDA: Office of Vaccines Research and Review (OVRR) Data Submission - May 8, 2018
	FDA Drug Topics: FDA's MedWatch Adverse Event Reporting Program - Opportunities to Collaborate - March 13, 2018
	FDA Drug Topics: FDA Adverse Events Reporting System (FAERS) Public Dashboard - January 30, 2018Past 2017 Webinars

CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft guidance for Industry: Information Requests and Discipline Review Letters Under GDUFA - December 15, 2017
	DDI Webinar Series: Overview of the Regulatory Framework and the Development and Approval of Biosimilar Products in the U.S. - December 5, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - REMS Integration Initiative: An Overview - December 4, 2017
	DDI Webinar Series: Tainted Products Marketed as Dietary Supplements - November 21, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Optimizing Your Study Data Submissions to FDA - Study Data Technical Conformance Guide October 2017 Version Update - November 8, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry: Controlled Correspondence Related to Generic Drug Development
	DDI Webinar Series: An Overview of FDA Resources - October 17, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry: Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry: Determining Whether to Submit an ANDA or 505(b)(2) Application
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry: ANDA Submissions - Amendments to Abbreviated New Drug Applications Under GDUFA II
	CDER SBIA extended webinar: Electronic Drug Registration & Listing Using CDER Direct - October 5, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry: Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Optimizing Your Study Data Submissions to FDA - Updates from CDER and CBER - July 13th 2017 - 1:00pm - 2:45pm (Eastern)
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - The Ins and Outs of Presenting Clinical Pharmacology Information in Prescription Drug Labeling - June 19th 2017 - 1:00pm - 2:30pm (Eastern)
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Risk Evaluation and Mitigation Strategies (REMS): A Deeper Dive - June 15th 2017 - 12:00pm - 3:00pm (Eastern)
	DDI Webinar Series: Fluoroquinolone Safety Labeling Updates- April 4, 2017
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - CDER Microbiology Issues: A Deeper Dive - March 15th, 2017
	DDI Webinar Series: FDA Post-Marketing Drug Safety Surveillance- March 7, 2017
	DDI Webinar Series: Collaborating with FDA- Get Involved with FDA's MedWatch Adverse Event Reporting Program - February 7, 2017Past 2016 Webinars

CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Annual Reporting Using CDER Direct: Technical Tips for Wholesale Drug Distributors and Third-Party Logistics Providers
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - An Overview of FDA's Guidance - Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification
	DDI Webinar Series: "Understanding Abuse Deterrent Opioids"- December 8, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Revised Draft Guidance for Industry: Submission of Quality Metrics Data
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - What's New with Forms FDA 3542a and 3542?
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Electronic Submission Requirements for ANDAs: Are You Ready? - November 21, 2016
	DDI Webinar Series: "The Etiologies of Drug Shortages"- November 8, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Overview of GDUFA II and Implementation of GDUFA II User Fees - October 28, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Study Data Standards in eCTD: What You Need to Know about the New Technical Rejection Criteria - October 12, 2016
	DDI Webinar Series: "FDA's Bad Ad Program and other Innovative FDA Collaborations" - October 6, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Establishment Registration and Listing for Human Drugs
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Submitting Risk Evaluation and Mitigation Strategies (REMS) in Structured Product Labeling (SPL) Format: What You Need to Know - August 24, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar: Stay Compliant! Electronic Submission of Drug Master Files (DMFs) is MANDATORY starting May 5, 2017: What You Need to Know - August 4, 2016
	CDER Small Business and Industry Assistance (SBIA) Webinar: CDER Direct Electronic Submission Portal: 503B Product Reporting (Compounding)
	DDI Webinar- "An Overview of FDA's Expanded Access Process and the New Individual Patient Expanded Access Application" - July 12, 2016
	DDI Webinar- "The Pregnancy and Lactation Labeling Rule (PLLR)" - April 14, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Pilot Clinical Outcome Assessment Compendium - March 8th, 2016
	DDI Webinar-"Introduction to Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER" - February 23, 2016
	DDI Webinar- "Introduction to FDA's MedWatch Adverse Reporting Program" - February 9, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - New Requirement for Electronic Submission of Drug Master Files (DMFs): What You Need to Know - February 4, 2016
	CDER Small Business and Industry Assistance (CDER SBIA) Webinar - Draft Guidance for Industry on Safety Assessment for IND Safety Reporting - February 1, 2016Resources

Division of Drug Information (DDI) Webinars
	SBIA Workshops and Webinars**2013-2015 webinar pages are archived. To view them, please see the **FDA Archive.**
To view the webinars, copy and paste the web address starting with https:// into a web browser.**

                                                                                  Content current as of:
      01/26/2024Drugs

          
                        


                        Regulatory Science Research and Education
          Development & Approval Process | Drugs
          Drug Safety and Availability
          Emergency Preparedness | Drugs
          Guidance, Compliance, & Regulatory Information
          News & Events for Human Drugs
          Resources | Drugs
          Science and Research | Drugs
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop